Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
- PMID: 19264732
- DOI: 10.1136/jmg.2008.062950
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype
Abstract
Background: The 9q subtelomeric deletion syndrome (9qSTDS) is clinically characterised by moderate to severe mental retardation, childhood hypotonia and facial dysmorphisms. In addition, congenital heart defects, urogenital defects, epilepsy and behavioural problems are frequently observed. The syndrome can be either caused by a submicroscopic 9q34.3 deletion or by intragenic EHMT1 mutations leading to haploinsufficiency of the EHMT1 gene. So far it has not been established if and to what extent other genes in the 9q34.3 region contribute to the phenotype observed in deletion cases. This study reports the largest cohort of 9qSTDS cases so far.
Methods and results: By a multiplex ligation dependent probe amplification (MLPA) approach, the authors identified and characterised 16 novel submicroscopic 9q deletions. Direct sequence analysis of the EHMT1 gene in 24 patients exhibiting the 9qSTD phenotype without such deletion identified six patients with an intragenic EHMT1 mutation. Five of these mutations predict a premature termination codon whereas one mutation gives rise to an amino acid substitution in a conserved domain of the protein.
Conclusions: The data do not provide any evidence for phenotype-genotype correlations between size of the deletions or type of mutations and severity of clinical features. Therefore, the authors confirm the EHMT1 gene to be the major determinant of the 9qSTDS phenotype. Interestingly, five of six patients who had reached adulthood had developed severe psychiatric pathology, which may indicate that EHMT1 haploinsufficiency is associated with neurodegeneration in addition to neurodevelopmental defect.
Similar articles
-
Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome.J Med Genet. 2005 Apr;42(4):299-306. doi: 10.1136/jmg.2004.028464. J Med Genet. 2005. PMID: 15805155 Free PMC article.
-
Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome.Hum Mutat. 2011 Jul;32(7):853-9. doi: 10.1002/humu.21523. Hum Mutat. 2011. PMID: 21538692
-
Familial Kleefstra syndrome due to maternal somatic mosaicism for interstitial 9q34.3 microdeletions.Clin Genet. 2011 Jul;80(1):31-8. doi: 10.1111/j.1399-0004.2010.01607.x. Epub 2011 Jan 10. Clin Genet. 2011. PMID: 21204793
-
The chromosome 9q subtelomere deletion syndrome.Am J Med Genet C Semin Med Genet. 2007 Nov 15;145C(4):383-92. doi: 10.1002/ajmg.c.30148. Am J Med Genet C Semin Med Genet. 2007. PMID: 17910072 Review.
-
A de novo subtelomeric monosomy 11q (11q24.2-qter) and trisomy 20q (20q13.3-qter) in a girl with findings compatible with Jacobsen syndrome: case report and review.Clin Dysmorphol. 2007 Oct;16(4):231-9. doi: 10.1097/MCD.0b013e3282742303. Clin Dysmorphol. 2007. PMID: 17786114 Review.
Cited by
-
Copy number variants in obesity-related syndromes: review and perspectives on novel molecular approaches.J Obes. 2012;2012:845480. doi: 10.1155/2012/845480. Epub 2012 Dec 17. J Obes. 2012. PMID: 23316347 Free PMC article. Review.
-
Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.Am J Hum Genet. 2012 Jul 13;91(1):73-82. doi: 10.1016/j.ajhg.2012.05.003. Epub 2012 Jun 21. Am J Hum Genet. 2012. PMID: 22726846 Free PMC article.
-
Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex.Neuron. 2009 Dec 10;64(5):678-91. doi: 10.1016/j.neuron.2009.11.019. Neuron. 2009. PMID: 20005824 Free PMC article.
-
CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency.Stem Cell Res Ther. 2022 Feb 9;13(1):69. doi: 10.1186/s13287-022-02740-3. Stem Cell Res Ther. 2022. PMID: 35139903 Free PMC article.
-
Chemical probes of histone lysine methyltransferases.ACS Chem Biol. 2015 Jan 16;10(1):40-50. doi: 10.1021/cb500785t. Epub 2014 Nov 25. ACS Chem Biol. 2015. PMID: 25423077 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases